The global event for Healthcare innovation, The Galien MedStartUp fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. The vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives. A focal point of the program is the active participation of the most innovative start-up companies working with US partners to share research and support the global commercial development of promising technologies.
The partnership of CBSET (US) and CILcare (France) has been nominated for the coveted Prix Galien MedStartUp in the category of "Best collaboration dedicated to the Developing or Underserved Populations worldwide."
The Prix Galien award was created in 1970 in honor of Galien, the father of medical science and modern pharmacology, and is awarded by the prestigious Prix Galien Foundation, considered by many to be the biopharmaceutical research equivalent of the Noble Foundation.